Skip to main content

Advertisement

Log in

Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Gotlib J, Cools J. Five years since the discovery of FIP1-PDGFR: what we have learned about the fusion and other molecularly defined eosinophilias. Leukemia. 2008;22:1999–2010.

    Article  CAS  PubMed  Google Scholar 

  2. Fletcher S, Bain B. Diagnosis and treatment of hypereosinophilic syndromes. Curr Opin Hematol. 2007;14:37–42.

    Article  CAS  PubMed  Google Scholar 

  3. Epstein F. Eosinophilia. N Engl J Med. 1998;338:1592–600.

    Article  Google Scholar 

  4. Valent P. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Blood Rev. 2009;23:157–65.

    Article  CAS  PubMed  Google Scholar 

  5. Pandit R, Scholnik A, Wulfekuhler L, Dimitrov N. Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome. Am J Hematol. 2007;82:234–7.

    Article  CAS  PubMed  Google Scholar 

  6. Uemura K, Nakajima M, Yamauchi N, Fukayama M, Yoshida K. Sudden death of a patient with primary hypereosinophilia, colon tumors, and pulmonary emboli. J Clin Pathol. 2004;57:541–3.

    Article  CAS  PubMed  Google Scholar 

  7. Anagnostopoulos G, Sakorafas G, Kostopoulos P, Margantinis G, Tsiakos S, Terpos E, et al. Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF. J Surg Oncol. 2005;89:273–5.

    Article  PubMed  Google Scholar 

  8. Kimura T, Mukai M, Kaneko Y, Hirakata M, Okamoto S, Sakamoto M, et al. Unusual hemangioendothelioma of the liver with epitheloid morphology associated with marked eosinophilia: Autopsy case. Pathol Int. 2007;56:694–701.

    Article  Google Scholar 

  9. Plumas J, Gruart V, Aldebert D, Truong J, Capron M, Capron L, et al. Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit. Eur J Immunol. 1990;21:1265–70.

    Article  Google Scholar 

  10. Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, et al. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood. 1991;78:2626–32.

    CAS  PubMed  Google Scholar 

  11. Collins P, Marleau S, Griffiths-Johnson D, Jose P, Williams T. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995;182:1169–74.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank the staff of the Department of Hematology and Rheumatology, Tohoku University for helpful discussions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideo Harigae.

About this article

Cite this article

Kato, H., Kohata, K., Yamamoto, J. et al. Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer. Int J Hematol 91, 328–330 (2010). https://doi.org/10.1007/s12185-010-0491-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-010-0491-2

Keywords

Navigation